Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nonspecific blood components and vascular tissue refers to the collective physical and chemical environment of the circulatory system, including plasma proteins, blood cells, and the endothelial lining of blood vessels (DrugBank Online, 2024). This category is typically used for drugs that exert their effects through non-specific physical or chemical mechanisms rather than binding to a specific molecular receptor (StatPearls, 2023). For example, plasma expanders like dextran increase oncotic pressure to treat hypovolemia, while osmotic diuretics like mannitol alter blood tonicity to reduce intracranial pressure (NIH, PubChem CID 6035). These interactions are crucial for managing conditions like shock, edema, and fluid imbalances (PubMed, PMC2596701). Because this "target" represents a physiological environment rather than a discrete molecule, it is primarily used for agents with non-specific or physical modes of action (DrugBank Online, 2024). This classification is essential for understanding the pharmacodynamics of substances that provide structural support, alter fluid dynamics, or serve as diagnostic contrast media within the vascular system.
Drugs acting on this target typically function through physical or chemical properties such as osmotic pressure modulation, volume expansion, or non-specific binding to plasma proteins and vessel walls.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nonspecific blood components and vascular tissue.